Held March 27, 2014
2:00pm EST - 3:30pm EST
Speakers: Steven Kleinman, MD; Kevin Land, MD; Mark Yazer, MD
Target Audience: Physicians, Medical Technologists, Nurses, Blood Bank Staff, Trauma Surgeons, Blood Center Managers
- Describe rationale for AABB's TRALI risk reduction standard.
- Explain the impact of TRALI risk reduction on plasma supply.
- Implement strategies to optimize plasma use in their hospital.
During this webinar, speakers will highlight recent transfusion-related acute lung injury requirements that may impact the supply of plasma components. After review of recent trends in plasma use in general and AB plasma use in particular, the speakers will highlight a number of strategies available to hospitals to optimize plasma use, including alternative therapies and recommendations for reducing group AB plasma use.
A recording of the March 27 webinar as well the session handout are available below.
Webinar Handout - Suggestions for Optimizing Use of Plasma in the Era of TRALI Risk Reduction (PDF)
Steven Kleinman, MD
Senior Medical Advisor, AABB
Dr. Steven Kleinman is Senior Medical Advisor to AABB and Clinical Professor of Pathology at the University of British Columbia. He has chaired the AABB TRALI Working Group since 2005 and he also chaired the TRALI Canadian Consensus Conference panel in 2004. His main interest is transfusion safety and he has published over 150 peer-reviewed scientific articles, over 20 book chapters, and co-edited two textbooks.
Kevin Land, MD
Senior Medical Director Field Operations
As senior corporate medical director for Blood Systems, Dr. Kevin Land is the lead physician in charge of Blood Systems' Patient Blood Management program. Through his career, Dr. Land has worked in both donor centers and hospitals and currently works with a Centralized Transfusion Service.
A Texas native, Dr. Land earned his bachelor's degree in Biochemistry in 1990 from the University of North Texas and completed his medical degree and residency in Pathology at UT Southwestern in Dallas. After serving as chief resident, he completed fellowships in medical informatics at Johns Hopkins and transfusion medicine at Parkland Memorial Hospital.
Among other honors, he currently chairs the AABB Donor Hemovigilance Working Group and is a Modern Healthcare's 2012 top clinical informaticist.
Mark Yazer, MD
Associate Professor of Pathology, University of Pittsburgh
Medical Director, RBC serology reference laboratory, Centralized Transfusion Service
Associate Medical Director, Centralized Transfusion Service
Dr. Mark Yazer is an associate professor of pathology at the University of Pittsburgh and an associate director of the centralized transfusion service. His research interests include patient blood management, transfusion practice and immunohematology.